Open AccessExcellent platinum dependent response to chemotherapy after relapse under TKI treatment in NSCLC with sensitizing EGFR mutations and no detectable resistance mutations: three case studies
Author(s) -
Diego Kauffmann-Guerrero,
Zulfiya Syunyaeva,
Kathrin Kahnert,
Amanda Tufman
Publication year - 2019
Publication title -
ame case reports
Language(s) - English
Resource type - Journals
ISSN - 2523-1995
DOI - 10.21037/acr.2019.09.02
Subject(s) - medicine , oncology , chemotherapy , lung cancer , epidermal growth factor receptor , tyrosine kinase , cohort , tyrosine kinase inhibitor , cancer , receptor